Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

BHVN Relative to the S&P 500

BHVN Relative to the Sector

Seasonal Chart Analysis

Analysis of the Biohaven Ltd. (NYSE:BHVN) seasonal charts above shows that a Buy Date of August 12 and a Sell Date of November 2 has resulted in a geometric average return of 42.3% above the benchmark rate of the S&P 500 Total Return Index over the past 8 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 8 years by an average of 23.78% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 8 years of data is available for shares of BHVN, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

To download BHVN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: BHVN